Endothelial dysfunction following drug-eluting stent implantation: A systematic review of the literature

International Journal of Cardiology

Volumn 165, Issue 2, 2013, Pages 222-228

  Minami, Yoshiyasu ^a   Kaneda, Hideaki ^b,c   Inoue, Masahiro ^d   Ikutomi, Masayasu ^a   Morita, Toshihiro ^a   Nakajima, Toshiaki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

^c FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^d Omigawa General Hospital   (Japan)

Author keywords

Drug eluting stent; Percutaneous coronary intervention; Vasoconstriction

Indexed keywords

ACETYLCHOLINE; PACLITAXEL; RAPAMYCIN; VASCULOTROPIN; ZOTAROLIMUS; NITRATE; UMIROLIMUS;

ADULT; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; BARE METAL STENT; CONTROLLED STUDY; DRUG ELUTING STENT; ENDOTHELIAL DYSFUNCTION; EXERCISE TEST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEOINTIMA; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; VASOCONSTRICTION; VASODILATATION; VASOMOTOR REFLEX; ACUTE HEART INFARCTION; CORONARY ARTERY CONSTRICTION; DRUG ELUTING CORONARY STENT; DRUG MEGADOSE; HEART PACING; STABLE ANGINA PECTORIS; STENT THROMBOSIS;

ANIMALS; CLINICAL TRIALS AS TOPIC; CORONARY VESSELS; DRUG-ELUTING STENTS; ENDOTHELIUM, VASCULAR; HUMANS;

EID: 84876671456     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.03.084     Document Type: Review

References (50)

1. M.C. Morice, P.W. Serruys, and J.E. Sousa A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 23 2002 1773 1780
2. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 14 2003 1315 1323
3. S. Windecker, A. Remondino, and F.R. Eberli Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization N Engl J Med 353 7 2005 653 662
4. R. Virmani, G. Guagliumi, and A. Farb Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109 6 2004 701 705
5. E. Camenzind, P.G. Steg, and W. Wijns Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern Circulation 115 11 2007 1440 1455 discussion 1455
6. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 1 2006 193 202
7. M. Togni, S. Windecker, and R. Cocchia Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction J Am Coll Cardiol 46 2 2005 231 236
8. S.H. Hofma, W.J. van der Giessen, and B.M. van Dalen Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation Eur Heart J 27 2 2006 166 170
9. S. Fuke, K. Maekawa, and K. Kawamoto Impaired endothelial vasomotor function after sirolimus-eluting stent implantation Circ J 71 2 2007 220 225
10. D.I. Shin, P.J. Kim, and K.B. Seung Drug-eluting stent implantation could be associated with long-term coronary endothelial dysfunction Int Heart J 48 5 2007 553 567
11. J.W. Kim, S.Y. Suh, and C.U. Choi Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent JACC Cardiovasc Interv 1 1 2008 65 71
12. D.I. Shin, K.B. Seung, and P.J. Kim Long-term coronary endothelial function after zotarolimus-eluting stent implantation. A 9 month comparison between zotarolimus-eluting and sirolimus-eluting stents Int Heart J 49 6 2008 639 652
13. J.W. Kim, H.S. Seo, and J.H. Park A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction J Am Coll Cardiol 53 18 2009 1653 1659
14. Fujii K, Kawasaki D, Oka K, Akahori H, Fukunaga M, Sawada H, et al. Endothelium-dependent coronary vasomotor response and neointimal coverage of zotarolimus-eluting stents 3 months after implantation. Heart 2011;97(12):977-82.
15. J.E. Obata, T. Nakamura, and Y. Kitta Treatment of acute myocardial infarction with sirolimus-eluting stents results in chronic endothelial dysfunction in the infarct-related coronary artery Circ Cardiovasc Interv 2 5 2009 384 391
16. J.E. Obata, Y. Kitta, and H. Takano Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction J Am Coll Cardiol 50 14 2007 1305 1309
17. Ito S, Nakasuka K, Morimoto K, et al. Angiographic and clinical characteristics of patients with acetylcholine-induced coronary vasospasm on follow-up coronary angiography following drug-eluting stent implantation. J Invasive Cardiol 2011;23(2):57-64.
18. Kitahara H, Kobayashi Y, Iwata Y, Fujimoto Y, Komuro I. Effect of pioglitazone on endothelial dysfunction after sirolimus-eluting stent implantation. Am J Cardiol 2011;108(2):214-219.
19. J.E. Gage, O.M. Hess, T. Murakami, M. Ritter, J. Grimm, and H.P. Krayenbuehl Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin Circulation 73 5 1986 865 876
20. O.M. Hess, A. Bortone, and K. Eid Coronary vasomotor tone during static and dynamic exercise Eur Heart J 10 Suppl. F 1989 105 110
21. M. Togni, L. Raber, and R. Cocchia Local vascular dysfunction after coronary paclitaxel-eluting stent implantation Int J Cardiol 120 2 2007 212 220
22. E.G. Nabel, A.P. Selwyn, and P. Ganz Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate Circulation 81 3 1990 850 859
23. M.I. Hamilos, M. Ostojic, and B. Beleslin Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion J Am Coll Cardiol 51 22 2008 2123 2129
24. M. Hamilos, J. Sarma, and M. Ostojic Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses Circ Cardiovasc Interv 1 3 2008 193 200
25. M. Sabate, I.P. Kay, and W.J. van Der Giessen Preserved endothelium-dependent vasodilation in coronary segments previously treated with balloon angioplasty and intracoronary irradiation Circulation 100 15 1999 1623 1629
26. P.R. Caramori, V.C. Lima, P.H. Seidelin, G.E. Newton, J.D. Parker, and A.G. Adelman Long-term endothelial dysfunction after coronary artery stenting J Am Coll Cardiol 34 6 1999 1675 1679
27. M. Togni, S. Windecker, and P. Wenaweser Deleterious effect of coronary brachytherapy on vasomotor response to exercise Circulation 110 2 2004 135 140
28. G. Guagliumi, A. Farb, and G. Musumeci Images in cardiovascular medicine. Sirolimus-eluting stent implanted in human coronary artery for 16 months: pathological findings Circulation 107 9 2003 1340 1341
29. A.V. Finn, F.D. Kolodgie, and J. Harnek Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents Circulation 112 2 2005 270 278
30. T.F. Luscher, J. Steffel, and F.R. Eberli Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications Circulation 115 8 2007 1051 1058
31. J. Kotani, M. Awata, and S. Nanto Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings J Am Coll Cardiol 47 10 2006 2108 2111
32. D. Matsumoto, J. Shite, and T. Shinke Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography Eur Heart J 28 8 2007 961 967
33. M. Guba, P. von Breitenbuch, and M. Steinbauer Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor Nat Med 8 2 2002 128 135
34. H. Jeanmart, O. Malo, M. Carrier, C. Nickner, N. Desjardins, and L.P. Perrault Comparative study of cyclosporine and tacrolimus vs newer immunosuppressants mycophenolate mofetil and rapamycin on coronary endothelial function J Heart Lung Transplant 21 9 2002 990 998
35. C.J. Bruns, G.E. Koehl, and M. Guba Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer Clin Cancer Res 10 6 2004 2109 2119
36. A. Jabs, S. Gobel, and P. Wenzel Sirolimus-induced vascular dysfunction. Increased mitochondrial and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production and decreased vascular nitric oxide formation J Am Coll Cardiol 51 22 2008 2130 2138
37. T. Shiroto, S. Yasuda, and R. Tsuburaya Role of Rho-kinase in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in pigs in vivo J Am Coll Cardiol 54 24 2009 2321 2329
38. H.M. Kwon, G. Sangiorgi, and E.L. Ritman Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique J Am Coll Cardiol 32 7 1998 2072 2079
39. C.W. Hwang, D. Wu, and E.R. Edelman Physiological transport forces govern drug distribution for stent-based delivery Circulation 104 5 2001 600 605
40. H. Kaneda, A. Yeung, and F. Ikeno Tissue sirolimus levels of distal vessel, stented myocardium, and distal myocardium JACC Cardiovasc Interv 1 5 2008 595 author reply 595
41. S. Cook, E. Ladich, and G. Nakazawa Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis Circulation 120 5 2009 391 399
42. D.M. Whelan, W.J. van der Giessen, and S.C. Krabbendam Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries Heart 83 3 2000 338 345
43. J.F. Beltrame, S. Sasayama, and A. Maseri Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients J Am Coll Cardiol 33 6 1999 1442 1452
44. C. Pristipino, J.F. Beltrame, and M.L. Finocchiaro Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction Circulation 101 10 2000 1102 1108
45. K. Maekawa, K. Kawamoto, and S. Fuke Images in cardiovascular medicine. Severe endothelial dysfunction after sirolimus-eluting stent implantation Circulation 113 23 2006 e850 e851
46. G.W. Stone, J.W. Moses, and S.G. Ellis Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 10 2007 998 1008
47. J. Wohrle, N. Marx, and W. Koenig Impact of pioglitazone on coronary endothelial function in non-diabetic patients with coronary artery disease Clin Res Cardiol 97 10 2008 726 733
48. B. Hornig, U. Landmesser, and C. Kohler Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase Circulation 103 6 2001 799 805
49. K.K. Ray, and C.P. Cannon The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes J Am Coll Cardiol 46 8 2005 1425 1433
50. P.W. Serruys, J.A. Ormiston, and Y. Onuma A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet 373 9667 2009 897 910